10-Q Filing

REGENXBIO INC. CIK: 1590877 Q1 2020

Filing Information

Form Type	10-Q
Accession Number	`0001564590-20-022890`
Period End Date	20200331
Filing Date	20200507
Fiscal Year	2020
Fiscal Period	Q1
XBRL Instance	rgnx-10q_20200331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 76 Income Statement 34 Cash Flow Statement 59 Stockholders Equity 18

Balance Sheet 76 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$69.41M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$69.51M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$55.85M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$226.70M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$209.85M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable	`AccountsReceivableGrossCurrent`	$44.52M	USD	Point-in-time
Accounts receivable	`AccountsReceivableGrossCurrent`	$38.15M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$7.42M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$6.47M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$4.20M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$7.03M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	37.19M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	36.99M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	36.99M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$338.23M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$345.03M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	37.19M	shares	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$77.36M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$103.78M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetNoncurrent`	$4.37M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetNoncurrent`	$4.16M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$30.41M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$28.97M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$9.38M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$10.08M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$1.33M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$1.33M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$1.05M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$2.85M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.55M	USD	Point-in-time
Total assets	`Assets`	$497.91M	USD	Point-in-time
Total assets	`Assets`	$463.94M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$9.01M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.41M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$24.85M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$20.33M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$2.45M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$2.42M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$31.79M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$33.68M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityNoncurrent`	$3.33M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityNoncurrent`	$3.33M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$8.87M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$7.99M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$1.83M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$672.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$47.71M	USD	Point-in-time
Total liabilities	`Liabilities`	$43.78M	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at March 31, 2020 and December 31, 2019	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at March 31, 2020 and December 31, 2019	`PreferredStockValue`	-	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at March 31, 2020 and December 31, 2019; 37,190 and 36,992 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively	`CommonStockValue`	$4.00K	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at March 31, 2020 and December 31, 2019; 37,190 and 36,992 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively	`CommonStockValue`	$4.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$638.59M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$627.81M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$205.00K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-580.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-217.86M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-177.82M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$487.05M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$450.20M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$508.85M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$420.15M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$463.94M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$497.91M	USD	Point-in-time

Income Statement 34 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$17.64M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$884.00K	USD	1 Quarter
Cost of revenues	`CostOfGoodsAndServicesSold`	$29.00K	USD	1 Quarter
Cost of revenues	`CostOfGoodsAndServicesSold`	$3.41M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$37.03M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$25.20M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$14.83M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$11.56M	USD	1 Quarter
Other operating expenses	`OtherOperatingIncomeExpenseNet`	$67.00K	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$36.79M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$55.34M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-37.70M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-35.91M	USD	1 Quarter
Interest income from licensing	`InterestIncomeFromLicencing`	$613.00K	USD	1 Quarter
Interest income from licensing	`InterestIncomeFromLicencing`	$848.00K	USD	1 Quarter
Investment income (loss)	`InvestmentIncomeNet`	$3.00M	USD	1 Quarter
Investment income (loss)	`InvestmentIncomeNet`	$-3.19M	USD	1 Quarter
Total other income (loss)	`NonoperatingIncomeExpense`	$3.61M	USD	1 Quarter
Total other income (loss)	`NonoperatingIncomeExpense`	$-2.34M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-40.04M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-32.30M	USD	1 Quarter
Income Tax Benefit	`IncomeTaxExpenseBenefit`	$70.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-40.04M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-32.23M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$621.00K	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-785.00K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$621.00K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-785.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-40.82M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-31.61M	USD	1 Quarter
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-0.89	USD	1 Quarter
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-1.08	USD	1 Quarter
Weighted-average basic and diluted common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	36.37M	shares	1 Quarter
Weighted-average basic and diluted common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	37.10M	shares	1 Quarter

Cash Flow Statement 59 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-32.23M	USD	1 Quarter
Net loss	`ProfitLoss`	$-40.04M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$8.02M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$5.72M	USD	1 Quarter
Net amortization of premiums and accretion of discounts on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$368.00K	USD	1 Quarter
Net amortization of premiums and accretion of discounts on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-39.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$1.99M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$1.61M	USD	1 Quarter
Net realized gains on sales and maturities of marketable securities	`AvailableForSaleSecuritiesGrossRealizedGainLossNet`	$7.08M	USD	1 Quarter
Imputed interest income from licensing	`ImputedInterestIncomeFromLicensing`	$848.00K	USD	1 Quarter
Imputed interest income from licensing	`ImputedInterestIncomeFromLicensing`	$613.00K	USD	1 Quarter
Unrealized losses on marketable equity securities	`AvailableForSaleEquitySecuritiesGrossUnrealizedLoss`	$12.20M	USD	1 Quarter
Other non-cash adjustments	`OtherNoncashIncomeExpense`	$-25.00K	USD	1 Quarter
Other non-cash adjustments	`OtherNoncashIncomeExpense`	$-327.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$5.74M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-591.00K	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$947.00K	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$790.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$2.83M	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$295.00K	USD	1 Quarter
Operating lease right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightOfUseAssets`	$-573.00K	USD	1 Quarter
Operating lease right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightOfUseAssets`	$-703.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-1.71M	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-26.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$3.06M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$316.00K	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-2.93M	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-3.81M	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-592.00K	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-851.00K	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-644.00K	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-1.16M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-35.57M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-29.30M	USD	1 Quarter
Purchases of marketable debt securities	`PaymentsToAcquireMarketableSecurities`	$30.69M	USD	1 Quarter
Purchases of marketable debt securities	`PaymentsToAcquireMarketableSecurities`	$79.25M	USD	1 Quarter
Maturities of marketable debt securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$87.17M	USD	1 Quarter
Maturities of marketable debt securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$60.91M	USD	1 Quarter
Sales of marketable equity securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$7.12M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.46M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.63M	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$5.46M	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$32.71M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$2.15M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$3.76M	USD	1 Quarter
Proceeds from issuance of common stock under employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$607.00K	USD	1 Quarter
Proceeds from issuance of common stock under employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$365.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.13M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.76M	USD	1 Quarter
Net decrease in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-103.00K	USD	1 Quarter
Net decrease in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-19.71M	USD	1 Quarter
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$70.74M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$56.91M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$70.84M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$76.61M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$70.74M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$56.91M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$70.84M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$76.61M	USD	Point-in-time

Stockholders Equity 18 line items

Line Item	Tag	Value	Unit	Period
Balances	`StockholdersEquity`	$487.05M	USD	Point-in-time
Balances	`StockholdersEquity`	$450.20M	USD	Point-in-time
Balances	`StockholdersEquity`	$508.85M	USD	Point-in-time
Balances	`StockholdersEquity`	$420.15M	USD	Point-in-time
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.15M	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.76M	USD	1 Quarter
Issuance of common stock under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$365.00K	USD	1 Quarter
Issuance of common stock under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$607.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$8.02M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$5.72M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$621.00K	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-785.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-40.04M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-32.23M	USD	1 Quarter
Balances	`StockholdersEquity`	$487.05M	USD	Point-in-time
Balances	`StockholdersEquity`	$450.20M	USD	Point-in-time
Balances	`StockholdersEquity`	$508.85M	USD	Point-in-time
Balances	`StockholdersEquity`	$420.15M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.